New hope for tough seizures: RAP-219 safety trial opens
NCT ID NCT07219407
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 26 times
Summary
This study tests the long-term safety of an experimental drug called RAP-219 in 30 adults with refractory focal epilepsy—seizures that don't respond well to current treatments. Participants must have completed a prior RAP-219 study. The main goal is to track side effects, while also measuring how well the drug controls seizures over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 770300, United States
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
-
Consultants in Epilepsy and Neurology, PLLC
RECRUITINGBoise, Idaho, 83702, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
NYU Langone Comprehensive Epilepsy Center
RECRUITINGNew York, New York, 10016, United States
-
University of Pennsylvania - Department of Neurology
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.